|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 高剂量美罗培南与多黏菌素B的联合:解决鲍曼不动杆菌碳青霉烯类耐药性问题的新策略显示文摘长期以来,多黏菌素与碳青霉烯类药物联合用于治疗碳青霉烯类耐药鲍曼不动杆菌的药效学研究较少。作者对多黏菌素B与高剂量美罗培南联合使用是否可以提高杀菌率以及抑制对碳青霉烯类耐药的产生进行了研究。 | 卞星晨 刘笑芬 Lenhard JR Bulitta JB Terry D | 2017 | 中国感染与化疗杂志2017，17，4： | 8 |
| 2 | Penetration of antibacterials into bone pharmacokinetic,pharmacodynamic and bioanalytical considerations显示文摘 | Landersdorfer CB Bulitta JB Kinzig M | 2009 | Clin Pharmacok2009，48，2： | 1 |
| 3 | Trospium chloride in patients with detrusor overacticity: recta-analysis of placebo controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily显示文摘 | Frohlich G Bulitta M Strosser W | 2002 | Int J Clin Pharmacol Ther2002，40，7： | 1 |
| 4 | Autoinduction of the trefoil factor 2 (TFF2) promoter requires an upstream cis -acting element显示文摘 | Clemens J Bulitta John V Fleming Raktima Raychowdhury Douglas Taupin Ian Rosenberg Timothy C Wang | 2002 | Biochemical and Biophysical Research Communications2002，，1： | 1 |
| 5 | Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus(MRSA):implications for dosing in MRSA pneumonia显示文摘 | Harigaya Y Bulitta JB Forrest A | 2009 | Antirmicrob Agents Chemother2009，53，9： | 1 |
| 6 | Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosaat multiple inocula显示文摘 | Bergen PJ Forrest A Bulitta JB | 2011 | Antimicrob Agents Chemother2011，55，11： | 1 |
| 7 | Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units 显示文摘 | ROOS J F BULITTA J LIPMAN J | 2006 | J Antimicrob Chemother2006，58，5： | 1 |
| 8 | Pharmacokinetic-ph-armacodynamic rationale for cefepime dosing regimens in intensive care units显示文摘 | Roos JF Bulitta J Lipman J | 2006 | JAntimicrob Chemother2006，58，5： | 1 |
| 9 | Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis显示文摘 | Koh TJ Bulitta CJ Fleming JV Dockray GJ Varro A | 2000 | J Clin Invest2000，106，： | 1 |
| 10 | Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations显示文摘 | Tsuji BT Bulitta JB Brown T | | J Antimicrob Chemother 20 12 90，67，9： | 1 |
| 11 | Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units显示文摘 | Roos JF Bulitta J Lipman J | 2006 | The Journal of antimicrobial chemotherapy2006，58，5： | 1 |
| 12 | Disposition,oral bioavailability,and tissue distribution of zearalenone in rats at various dose levels显示文摘 | Shin BS Hong SH Bulitta JB | 2009 | J Toxical Environ Health A2009，72，2122： | 1 |
| 13 | Trospium chloride in patients with detrusor overactivity: meta-analysis of placebocontrolled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20mg trospium chloride twice daily显示文摘 | FROHLICH G BULITTA M STROSSER W | 2002 | Int J Clin Pharmacol Ther2002，40，7： | 1 |
| 14 | Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model显示文摘 | Bergen P J Tsuji B T Bulitta J B | | 0，，12： | 1 |
| 15 | Nonlinear pharmacokinetics of piperacillin in healthy volunteersimplications for optimal dosage regimens显示文摘 | Bulitta JB Kinzig M Jakob V | | 0，，： | 1 |
| 16 | Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against muhidrug-resistant Pseudomonas aeruginosa at multiple inocula显示文摘 | Bergen PJ Forrest A Bulitta JB | 2011 | Antimicrob Agents Chemother2011，55，11： | 1 |
| 17 | Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis显示文摘 | Koh TJ Bulitta CJ Fleming JV | 2000 | J Clin Invest2000，106，： | 1 |
| 18 | Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers显示文摘 | Pletz MW Rau M Bulitta J | 2004 | Antimicrob Agents Chemother2004，48，10： | 1 |
| 19 | Gastrinis atarget of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis显示文摘 | Koh TJ Bulitta CJ Fleming JV | 2000 | J Clin Invest2000，106，53： | 1 |
| 20 | Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers显示文摘 | Krueger WA Bulitta J Kinzig-Schippers M | 2005 | Antimicrob Agents Chemother2005，49，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员